Skip to main content
Top
Published in: Endocrine Pathology 1/2015

01-03-2015

Letter to the Editor

Authors: Kalman Kovacs, Fabio Rotondo, Eva Horvath, Luis V. Syro, Antonio Di Ieva, Michael D. Cusimano, David G. Munoz

Published in: Endocrine Pathology | Issue 1/2015

Login to get access

Excerpt

We read Dr. Trouillas’ recent article published in Endocrine Pathology (25: 124–132, 2014), with great interest. Earlier attempts have been made to create a proper classification for pituitary tumors, yet a proper classification is still unresolved. Dr. Trouillas and colleagues’ effort should be applauded. However, we believe the proposed classification is complicated and, unfortunately, not as reliable as it may seem. Implementing it would be extremely time consuming and expensive and not only add extra burden to already strained resources in pathology departments around the world but also be achievable by few. To go to this expense for little gain would not advance the care of patients with pituitary tumors. …
Metadata
Title
Letter to the Editor
Authors
Kalman Kovacs
Fabio Rotondo
Eva Horvath
Luis V. Syro
Antonio Di Ieva
Michael D. Cusimano
David G. Munoz
Publication date
01-03-2015
Publisher
Springer US
Published in
Endocrine Pathology / Issue 1/2015
Print ISSN: 1046-3976
Electronic ISSN: 1559-0097
DOI
https://doi.org/10.1007/s12022-014-9342-7

Other articles of this Issue 1/2015

Endocrine Pathology 1/2015 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.